Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02189174
Title Study of CLR457 Administered Orally in Adult Patients With Advanced Solid Malignancies
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications

Advanced Solid Tumor

Therapies

CLR457

Age Groups: adult
Covered Countries USA | CAN

Additional content available in CKB BOOST